- The Wall Street Journal•3 hours ago
Bayer and U.S. healthcare investor Versant Ventures plan to establish a stem-cell research company called BlueRock Therapeutics, with initial joint funding of $225 million.
- Business Insider•6 hours ago
A French biotech company just took a crucial step toward preventing vexing new cases of Lyme...
- Financial Times•3 days ago
Cave canem, even pooches. The Competition and Markets Authority has fined US drug titan Pfizer £84m for unfairly propelling the price of a must-have anti-epilepsy drug skyward. It is the biggest fine levied ...
GSK.L : Summary for GLAXOSMITHKLINE PLC ORD 25P - Yahoo Finance
GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
|Bid||1,462.00 x 175400|
|Ask||1,499.00 x 417900|
|Day's Range||1,463.00 - 1,482.50|
|52 Week Range||1,277.25 - 1,745.56|
|PE Ratio (TTM)||242.30|
|Dividend & Yield||0.95 (5.18%)|
|1y Target Est||N/A|